Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.

• Authors: X F Mayol, J Beltran, R Rubio-Bazan, J Rifa, R R Costa, J J Lopez
• Journal: Cancer treatment reports (Cancer Treat Rep) Vol. 68 Issue 9 Pg. 1199-200 (Sep 1984) ISSN: 0361-5960 [Print] United States
• PMID: 6444204 (Publication Type: Journal Article)

Chemical References

• Vinblastine
• Vindesine

Topics

• Adult
• Aged
• Drug Administration Schedule
• Drug Evaluation
• Female
• Humans
• Infusions, Parenteral
• Male
• Melanoma (drug therapy, secondary)
• Middle Aged
• Vinblastine (administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
• Vindesine